By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Campus Vienna Biocenter 2
Viehmarktgasse 2A
Vienna    1030  Austria
Phone: 43-01-7981575-10 Fax: 43-01-7981575-11



Start Up

Company News
AFFiRiS AG: Vaccination Against Hypertension is Development Project No. 4 2/25/2010 7:38:11 AM
AFFiRiS GmbH: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 11/19/2009 11:14:18 AM
AFFiRiS GmbH Encouraging Results From Phase I Studies of two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment 10/20/2009 8:58:10 AM
AFFiRiS GmbH: Atherosclerosis Vaccine Development Receives EU Support 5/27/2009 9:36:52 AM
AFFiRiS GmbH Begins Development of a Parkinson's Vaccine 12/11/2008 9:30:34 AM
GlaxoSmithKline (GSK) (JOBS), AFFiRiS GmbH Ink $553 Million Alzheimer Vaccine Deal 10/23/2008 10:09:46 AM
MIG-Fonds Increases Investment in AFFiRiS GmbH by Euro 3 Million 9/25/2008 10:45:43 AM
AFFiRiS GmbH Milestone Reached in Clinical Trial of Alzheimer's Vaccine 7/16/2008 8:12:58 AM
AFFiRiS GmbH Begins Clinical Testing of Alzheimer's Vaccine 7/19/2007 8:49:58 AM
Austria's AFFiRiS GmbH Inks $10.4 Million Series A For Therapeutic Vaccine Devt 4/7/2006 12:15:45 PM